That is necessary, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (artificial intelligence). However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. This was an advancement almost nobody noticed. But it's going to have extensive implications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown tech stock 2021). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back possibly significantly prior to going higher - jeff brown 1 biotech. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of great private business on the brink of striking the public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This opportunity has been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area for free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (black sea). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we understand (the legacy report predictions). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential development and developing unbelievable opportunities for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown predictions 2021. But in spite of what lots of readers may believe, this is a pattern that's just starting. Although the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (longtime readers). Losing 2 months of production and sales really affects the number of 5G devices are offered in the calendar year. When you think about all of that, selling 250 million units is impressive. More importantly, the hold-ups brought on by the pandemic produced a lots of pent-up demand. And that need is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown top biotech stock 2021. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its 3 different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services start to be offered (jeff brown biotech stock). That's when we begin to see applications working on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer season. This starts something of a virtuous cycle: The majority of people don't actually appreciate the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of incredible applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial technology I foresee in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For years, CRISPR was mostly a niche technology that wasn't well comprehended. And during that time, there were really only 3 companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're treating illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This whole market is effectively a greenfield chance.
There's room for many companies to exist in this space. jeff bezos. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is very important due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug treatments produced using this innovation. This was among those developments that nearly no one saw. But it's going to have profound ramifications for treating illness. And, obviously, there will be plenty of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe considerably prior to going higher. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever published was on bitcoin - exponential growth. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown 2021 stock predictions. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, but we might not individually validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional viewpoint on the market. He's always on the hunt for brand-new opportunities, and he shares much of his best picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted a few of the most significant financial occasions of the previous 20 years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have earned him legions of devoted followers. That says a lot about his ability. The Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study provides a number of research study services with a wide range of expertises - the legacy report prediction.
The company is likewise connected with Bonner & Partners, another well-respected research study publisher - tech predictions. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been offered to specific financiers. It has been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown predictions for 2021. The objective of Brownstone Research is to make that kind of exclusive research readily available to any investors aiming to acquire an edge in the markets. The objective is simple to deliver special and lucrative financial investment research discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise serves as the firm's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. self-driving cars. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. jeff brown biotech stock pick for 2020. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: expert system and electrical automobiles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile industry's Holy Grail. As you know, electric lorries and self-driving cars and truck stocks have been big this year, however the Wall Street machine has approved buzz without much concrete outcome. Despite an extreme increase in competition over the past few years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech might be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transport. Generally, this technology would allow you to lease out your vehicle as an autonomous, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that informs the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the profits. It sounds outrageous, however it could be closed than you think.